Calamos Advisors »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Calamos Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $60M 51M 1.17
2024-06-30 $51M 47M 1.08
2024-03-31 $44M 47M 0.94
2023-12-31 $56M 56M 0.99
2023-09-30 $52M 56M 0.93

More positions owned by Calamos Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
UnitedHealth (UNH)

View all positions for Calamos Advisors

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Deerfield Management Company
Aequim Alternative Investments
Lazard Asset Management
BlackRock
Davidson Kempner Capital Management
Calamos Advisors
Invesco
BlackRock
State Street Corporation
Morgan Stanley
MacKay Shields
Shenkman Capital Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1